Association Between Temporal Changes in Life's Simple 7 Cardiovascular Health Metrics and Recurrent Coronary Heart

Yihong Ding1, Hui Chen2, Qingyong Zeng1

  • 1Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China (Y.D., Q.Z., D.H.).

Insights

Improving cardiovascular health using Life's Simple 7 (LS7) significantly reduces the risk of recurrent coronary heart disease (CHD). Maintaining or enhancing LS7 scores is crucial for managing patients with CHD and preventing future cardiac events.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) recurrence poses a significant health risk.
  • Life's Simple 7 (LS7) is a measure of cardiovascular health, but its prognostic role in patients with existing CHD is not well-established.

Purpose of the Study:

  • To investigate the association between changes in Life's Simple 7 (LS7) scores and the risk of recurrent coronary heart disease (CHD).

Main Methods:

  • Utilized data from the US ARIC study, assessing LS7 scores at two time points (Visit 1 and Visit 3).
  • Analyzed changes in LS7 categories, cumulative scores, and score changes (Δscore) in relation to recurrent CHD events.
  • Employed Cox proportional hazards models to evaluate the associations.

Main Results:

  • An improvement in LS7 score from poor/fair to moderate/ideal was linked to a 46% reduced risk of recurrent CHD (HR, 0.54).
  • A decline in LS7 score from moderate/ideal to poor/fair increased the risk of recurrent CHD (HR, 1.82).
  • Higher cumulative LS7 scores and greater increases in LS7 scores were associated with significantly lower risks of recurrent CHD.

Conclusions:

  • Deterioration of cardiovascular health, as indicated by LS7 scores, is associated with increased recurrent CHD risk.
  • Improvements in LS7 scores correlate with a reduced risk of recurrent CHD events.
  • Longitudinal assessment and improvement of cardiovascular health are vital for managing patients with CHD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...